You just read:

New Data Suggests Improved Tumor Response For The Combination of AZIXA® and Immune Checkpoint Inhibitors in The Treatment of Cancer

News provided by

Immune Pharmaceuticals Inc.

Jun 28, 2016, 07:00 ET